S Schröder1, U Reineke, M Lehmann, J Ebmeyer, H Sudhoff. 1. Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Halschirurgie, Klinikum Bielefeld, Deutschland. stefanie.schroeder@klinikumbielefeld.de
Abstract
BACKGROUND: Sufficient diagnostic tools and effective therapies for chronic obstructive eustachian tube dysfunction are lacking. PATIENTS AND METHODS: A total of 120 patients (209 ears) with chronic obstructive eustachian tube dysfunction were treated over a 2-year period using transnasal endoscopic balloon dilatation of the cartilaginous part of the eustachian tube (balloon eustachian tuboplasty, BET). A balloon catheter is inserted into the eustachian tube via the pharyngeal opening and dilated with a pressure of 10 bar for 2 min. RESULTS: The first 12 patients (20 dilatations) had a pretreatment average tube score of 1.25 (± 1.83 SD), and 1 year after treatment, the score improved to 6.2 (± 2.61 SD). Furthermore, the pretreatment and 2-month posttreatment data of 66 additional patients (115 dilatations) were analyzed. In these patients, the tube score improved significantly from 2.21 (± 2.02 SD) to 5.4 (± 2.53 SD). CONCLUSION: The initial long-term results suggest that BET is feasible and safe for the treatment of chronic obstructive eustachian tube dysfunction.
BACKGROUND: Sufficient diagnostic tools and effective therapies for chronic obstructive eustachian tube dysfunction are lacking. PATIENTS AND METHODS: A total of 120 patients (209 ears) with chronic obstructive eustachian tube dysfunction were treated over a 2-year period using transnasal endoscopic balloon dilatation of the cartilaginous part of the eustachian tube (balloon eustachian tuboplasty, BET). A balloon catheter is inserted into the eustachian tube via the pharyngeal opening and dilated with a pressure of 10 bar for 2 min. RESULTS: The first 12 patients (20 dilatations) had a pretreatment average tube score of 1.25 (± 1.83 SD), and 1 year after treatment, the score improved to 6.2 (± 2.61 SD). Furthermore, the pretreatment and 2-month posttreatment data of 66 additional patients (115 dilatations) were analyzed. In these patients, the tube score improved significantly from 2.21 (± 2.02 SD) to 5.4 (± 2.53 SD). CONCLUSION: The initial long-term results suggest that BET is feasible and safe for the treatment of chronic obstructive eustachian tube dysfunction.
Authors: Michael B Gluth; Darren R McDonald; Amy L Weaver; Christopher D Bauch; Charles W Beatty; Laura J Orvidas Journal: Arch Otolaryngol Head Neck Surg Date: 2011-05
Authors: Carsten V Dalchow; M Loewenthal; N Kappo; F Jenckel; B B Loerincz; R Knecht Journal: Eur Arch Otorhinolaryngol Date: 2015-03-19 Impact factor: 2.503